Brought to you by 
French drug delivery technology company Flamel does US IPO
13 Jul 1999
Executive Summary
French drug delivery company Flamel Technologies SA has gone public in the US, raising net proceeds of $26.6mm by selling 2.4mm American Depository Shares at $12 per share. The company's CEO, as a selling shareholder, placed an additional 120,000 ADSs.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
French drug delivery technology company Flamel does US IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice